Novel Essential-Tremor Treatment Gets US Green Light
Executive Summary
The ExAblate Neuro uses targeted ultrasound to destroy brain tissue linked to tremors. It is the first device of its type to gain approval from the US regulator.
You may also be interested in...
Trial Shows InSightec's Tremor Therapy Could Improve With Better Imaging
Results of a small clinical trial of tractography-based ventral intermediate nucleus-targeting suggest this MRI-based imaging approach could help improve the outcomes of focused ultrasound brain intervention with InSightec's Exablate Neuro system for the noninvasive treatment of essential tremor.
InSightec’s Focused Ultrasound Shows Early, Positive Data For Disabling Tremor
The results are an encouraging sign not only for the company but also for the novel device development model employed by the trial’s sponsor, the Focused Ultrasound Foundation.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.